TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says January 20, 1995
TCL Archive NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan. March 11, 2005